Print

Phage Pharmaceuticals (Formerly Known as Phage Biotechnology Corp.) Appoints David Jackson as Vice President, Operations Planning  
7/19/2010 10:27:06 AM

SAN DIEGO & NEW YORK--(BUSINESS WIRE)--Phage Pharmaceuticals, Inc., a clinical-stage developer and manufacturer of therapeutic proteins, announced today that it has appointed David Jackson to the position of Vice President, Operations Planning. In this role, Mr. Jackson is responsible for oversight of the company’s cGMP-certified therapeutic protein manufacturing facility in San Diego. He reports to Robert J. Beckman, CEO of Phage Pharmaceuticals.
//-->